Header Logo

Connection

JOSEPH KASS to Janus Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications JOSEPH KASS has written about Janus Kinase Inhibitors.
JOSEPH KASS
Connection Strength
0.041
Janus Kinase Inhibitors
  1. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper. Front Immunol. 2020; 11:1648.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.